display

Amsterdam (dpa) - The corona vaccine from the US manufacturer Johnson & Johnson can be used without restriction in the EU after testing by the EU Medicines Agency (EMA).

In very rare cases, the active ingredient could trigger blood clots, the EMA announced in Amsterdam.

It was already stated in advance that the “benefits of the vaccine to prevent Covid-19” should be rated higher than the risks of side effects.

The experts from the Amsterdam authority had re-examined the vaccine after six cases of blood clots in cerebral veins occurred in the United States.

display

Johnson & Johnson had only started delivering its preparation to the EU countries a week ago.

The manufacturer called for the vaccine not to be used until clarified.

In the United States, around 6.8 million people have been vaccinated with the Johnson & Johnson vaccine to date.

© dpa-infocom, dpa: 210420-99-280213 / 3